6-1390207-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001452.2(FOXF2):c.260G>A(p.Gly87Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000849 in 1,531,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001452.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXF2 | NM_001452.2 | c.260G>A | p.Gly87Asp | missense_variant | 1/2 | ENST00000645481.2 | NP_001443.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXF2 | ENST00000645481.2 | c.260G>A | p.Gly87Asp | missense_variant | 1/2 | NM_001452.2 | ENSP00000496415 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151288Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000675 AC: 1AN: 148150Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82676
GnomAD4 exome AF: 0.00000725 AC: 10AN: 1380082Hom.: 0 Cov.: 30 AF XY: 0.0000117 AC XY: 8AN XY: 683100
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151288Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73866
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.260G>A (p.G87D) alteration is located in exon 1 (coding exon 1) of the FOXF2 gene. This alteration results from a G to A substitution at nucleotide position 260, causing the glycine (G) at amino acid position 87 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at